Assessing Practice Patterns of Antidepressant Medication and Tamoxifen Use Among Patients With Hormone Receptor-Positive Breast Cancer. [PDF]
Lopetegui-Lia N +8 more
europepmc +1 more source
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing. [PDF]
Tašková I, Šafářová N, Hahn M.
europepmc +1 more source
Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]
Görnert C +6 more
europepmc +1 more source
Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D6. [PDF]
Tang TY +4 more
europepmc +1 more source
Role of Pharmacogenetics on Tramadol Pharmacokinetics: A Population Pharmacokinetic Model. [PDF]
Soria-Chacartegui P +6 more
europepmc +1 more source
Clinical Evaluation of Drug-Drug Interactions With Aficamten. [PDF]
Maharao N +11 more
europepmc +1 more source
Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles. [PDF]
Bennett MH +6 more
europepmc +1 more source
Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics. [PDF]
Tobin KV +4 more
europepmc +1 more source
A functional ancestry-linked regulatory haplotype influences CYP2D6 expression. [PDF]
McCoy M.
europepmc +1 more source
Impact of Mild Traumatic Brain Injury (mTBI) on CYP2D6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation. [PDF]
Berenjian K +5 more
europepmc +1 more source

